3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Hepatocellular
37
Liver Neoplasms
20
Neoplasms
17
Leukemia, Myeloid, Acute
13
Neoplasm Metastasis
11
Carcinoma, Renal Cell
9
Carcinoma, Non-Small-Cell Lung
9
Pancreatic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Melanoma
7
Breast Neoplasms
6
Brain Neoplasms
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Prostatic Neoplasms
5
Multiple Myeloma
5
Lung Neoplasms
5
Kidney Neoplasms
5
Recurrence
4
Glioblastoma
4
Colorectal Neoplasms
4
Sarcoma
3
Rectal Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Promyelocytic, Acute
3
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Erythroblastic, Acute
3
Leukemia, Eosinophilic, Acute
3
Interventions
Gemcitabine
4
pembrolizumab
3
Docetaxel
3
aflibercept
2
Trastuzumab
2
Specimen Handling
2
Cisplatin
2
Carboplatin
2
vinflunine
1
tipifarnib
1
erdafitinib
1
enzalutamide
1
entinostat
1
enfortumab vedotin
1
cabozantinib
1
avelumab
1
Thalidomide
1
Sorafenib
1
Ramucirumab
1
Radiotherapy
1
Platinum
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Ipilimumab
1
Introns
1
Interleukin-12 Subunit p35
1
Interleukin-12
1
Interferon-alpha
1
Interferon alpha-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Urethral Neoplasms
×
Sorafenib
×
Clear all
NCT01844947
2019-04-26
VINSOR
Karolinska University Hospital
Phase 1
Completed
22 enrolled